MEILIN DIAZ-PAEZ: Open Payments
NPI 1033539333 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 9 payments from 7 companies in 2025. Trend: 2023 $4,075 · 2024 $1,401 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $62 |
| Legend Biotech USA Inc. | 1 | $40 |
| Genentech USA, Inc. | 1 | $33 |
| SOBI, INC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: REZUROCK, CARVYKTI, Phesgo, Doptelet, ICLUSIG, JAKAFI, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
